Sentences with phrase «global futures program»

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

That China has even embarked on an aircraft carrier program speaks volumes about their future role in global security.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

The alliance grew out of Schultz's and ASU president Dr. Michael Crow's participation in the Markle Economic Future Initiative, a program committed to expanding opportunities that help Americans succeed in today's global and digital economy.

The Program applies the latest thinking in public finance and resource policy to assess how governments can improve the global competitiveness of the energy sector, improve the understanding of the need for energy market access, foster the innovation that will create the energy sector of the future, and help policymakers collaborate locally, nationally and globally.

Ripple is pleased to share the news that our VP of Global Sales and Client Relations Nilesh Dusane is part of the very first BAFT Future Leaders Program.

Schwarzman Scholars is a highly selective, one - year master's program at Tsinghua University in Beijing that is designed to prepare the next generation of global leaders for the challenges of the future.

I noted that the Italian BOND FUTURES Monday were trading above the June 27 close when ECB President Mario Draghi roiled global credit markets with his Sintra, Portugal speech, which suggested that the removal of a deflationary scare would allow the ECB to begin tapering its QE program.

Draper University designs and delivers world - class entrepreneurship and innovation education programs for a global audience with a future focus.

«Our aim is to complete a program that would normally take four years and do it in half the time, while still doing it right,» said Dag Reckhorn, Vice President of Global Manufacturing at Faraday Future.

By supporting organizations and programs that will leave our world in better shape for the next generation, we are confident that LexCorp can help to create a stable and properous global economy of the future.

Examples of these risks, uncertainties and other factors include, but are not limited to the impact of: adverse general economic and related factors, such as fluctuating or increasing levels of unemployment, underemployment and the volatility of fuel prices, declines in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence; adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events; the risks and increased costs associated with operating internationally; our expansion into and investments in new markets; breaches in data security or other disturbances to our information technology and other networks; the spread of epidemics and viral outbreaks; adverse incidents involving cruise ships; changes in fuel prices and / or other cruise operating costs; any impairment of our tradenames or goodwill; our hedging strategies; our inability to obtain adequate insurance coverage; our substantial indebtedness, including the ability to raise additional capital to fund our operations, and to generate the necessary amount of cash to service our existing debt; restrictions in the agreements governing our indebtedness that limit our flexibility in operating our business; the significant portion of our assets pledged as collateral under our existing debt agreements and the ability of our creditors to accelerate the repayment of our indebtedness; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; fluctuations in foreign currency exchange rates; overcapacity in key markets or globally; our inability to recruit or retain qualified personnel or the loss of key personnel; future changes relating to how external distribution channels sell and market our cruises; our reliance on third parties to provide hotel management services to certain ships and certain other services; delays in our shipbuilding program and ship repairs, maintenance and refurbishments; future increases in the price of, or major changes or reduction in, commercial airline services; seasonal variations in passenger fare rates and occupancy levels at different times of the year; our ability to keep pace with developments in technology; amendments to our collective bargaining agreements for crew members and other employee relation issues; the continued availability of attractive port destinations; pending or threatened litigation, investigations and enforcement actions; changes involving the tax and environmental regulatory regimes in which we operate; and other factors set forth under «Risk Factors» in our most recently filed Annual Report on Form 10 - K and subsequent filings by the Company with the Securities and Exchange Commission.

If in the 1970s we had begun a program of efficient use and switching gradually to other sources of energy, «peak oil» would remain quite far in the future and there might still be some chance to reduce global warming.

Building on current programs and efficiencies that reduce water and energy use and greenhouse gas emissions, the new Bacardi Limited global platform, Good Spirited: Building a Sustainable Future, reinforces the Company's leadership in corporate social responsibility (CSR).

But in a sign of his increasing concern about the future of the national and global economy, de Blasio said he considering instituting some kind of forcible savings or PEG program in his executive budget, which will be released in May.

Rather, the world's largest oil company maintained that all sources of energy, including fossil fuels, will be necessary to meet the future global demand and that the best path toward managing greenhouse gas emissions is through technology advancement and adoption of energy efficiency programs.

The Pew Environment Group's Global Ocean Legacy program has set its sights on two further massive protection areas in the near future: they hope to see New Zealand approve a 630,000 square km area in the Kermadec Islands later this year, and Australia protect 900,000 square km in the Coral Sea in 2012.

With global collaborations, we can identify strategic future investments in marine protected areas, and track progress towards better outcomes,» said Dr. Emily Darling, Associate Conservation Scientist at Wildlife Conservation Society, who leads a global coral reef monitoring program.

It is not mentioned in any of the 169 targets, yet many people think it is a decisive factor for global environmental change and future human wellbeing,» says IIASA World Population Program Director Wolfgang Lutz, a study coauthor.

Currently a Master's Student in the Global Medicine program at the Keck School of Medicine at USC with an emphasis on management, Anthony have plans to further his education by attending medical school in the future.

It is here that potential future art house stalwarts combine with the late night classics of tomorrow, and that a global panorama of the best contemporary work sits alongside challenging sidebars and endearing retrospective programming.

All believe in the values of the YLI program and share the vision of future leaders» development as a critical component underlying supporting the growth of Indonesia.Indonesia is a member of the G20, ranks as the 3rd reviews largest democracy in the world, with 240 million people and rich natural resources; it has increasingly played an important role in the global stage.

After Rio +20: Moving Beyond 2015 Peoples» Sustainability Treaties in a Post Rio +20 Future: Advancing a Global Citizens Movement Around Sustainable Development A week - long set of Workshop Panels, 15 - 19th October, 2012 at Ramapo College, Mahwah, NJ, USA SC 137 PROPOSED PROGRAM (Subject to revision) Day 01 / October 15, 2012 «Rio +20: A Critical Analysis» 09.30 AM — 9:55 AM Registration 9:55 AM — 10:00 AM Dr. -LSB-...]

During the meeting Mr. Khatri talked about the job of UNESCO with the Ministry of Education in Cambodia, the special programs developed to combat literacy, the law number of students at schools, and also about the future Global Citizenship Education proposed by UNESCO.

These programs lay the foundation of the nation's future workforce and global competitiveness.

ICSEI 2015 themes draw on the best of research and professional wisdom to explore the history and future of school reform; teacher effects from 1970s to the present; school - and system - level improvements; and the global and local implications of the 2013 Program for International Student Assessment (PISA) scores.

Our program combines critical knowledge from experienced international school leaders with an internationally seasoned and passionate leadership mentor who will challenge your learning and assist with the global networking essential to a successful and well - connected leadership future.»

The goal of this program is to have future teachers gain a global perspective while also learning skills they'll need in the classroom.

Hydrogen - powered fuel - cell development programs fell off the automotive radar screen when the global economy faltered in 2008 and automakers focused on immediate survival rather than future products.

Partnerships between states and railroads are central to the Obama Administration's vision for a national high - speed rail program, which will allow America to win the future by creating construction and manufacturing jobs here in the U.S., while promoting future economic growth and global competitiveness.

Ford Global Technologist John Ellis visits SEMA Central to discuss the future of vehicle technology integration, including SEMA's new Vehicle Electronics Program.

To help provide a safer and healthier future for all the animals on Vieques, The HSUS and its global arm, Humane Society International, are working with locals on projects ranging from spay / neuter clinics for companion animals to a contraceptive program for horses.

In addition to overseeing Marriott's award winning loyalty programs, Marriott Rewards, which includes The Ritz - Carlton Rewards, and Starwood Preferred Guest, Flueck will provide global leadership and strategic direction for the future combined loyalty program.

Allison Schulnik, Arin Rungjang, art fair, artist studio, Australian Centre for the Moving Image, Boyd Webb, Callum Innes, Charles Lim, collectors, commercial, contemporary art, creativity, culture, Digital Art, discussions, exhibition, fair, Future Perfect, Galeria AFA, galleries, gender, Gene Sherman, global, Google Creative Lab, Ian Hamilton Finlay, Ingleby Gallery, installation, Joachim Bandau, Joana Vasconcelos, Jonathan Owen, Josh Azzarella, Katie Paterson, Mark Moore Gallery, Moving Image, Pearl Lam Galleries, performance, Peter Liversidge, post internet, public program, Qin Yufen, Richard Forster, Sandra Vasquez de la Horra, studio visits, Su Xiaobai, Sydney Art Week, Sydney Contemporary, Tim Etchells, Two Rooms, video art, Yinka Shonibare Mbe, Zhu Jinshi

Thompson and Dyangani Ose are expected to collaborate on Creative Time's future programming, presenting important contemporary art that breaks down geographic, racial, and socioeconomic barriers and prioritizes cultivating a broader global audience.

Highlights of Broad MSU exhibitions in 2014 include: Future Returns: Contemporary Art from China — an exhibition featuring the response of over 20 contemporary Chinese artists to the country's rapid development and cultural transformation; Land Grant: The Flatbread Society, a commissioned site - specific work and series of public programs to explore food production, distribution, and farming methods; and the continuation of Broad MSU's Global Focus exhibition series — an initiative showcasing international emerging and mid-career artists.

«This program for saving the Congo was a fundamental pillar of their vision for the future of their countries,» he said, adding that they emphasized the global benefits of forest conservation.

I will continue to support the US Global Change Research Program and ensure that the program's activities support the Nation's needs for climate related information to help it prepare for the Program and ensure that the program's activities support the Nation's needs for climate related information to help it prepare for the program's activities support the Nation's needs for climate related information to help it prepare for the future.

Only if the world's population can be decreased by several billion through a strong global birth reduction and limiting program before we reach subsistence for all of us, will many future generations be able to exist.

Projects that combine national resources with international development initiatives such as the World Bank's Water Global Practice or the Asian Development Bank's Water for All program could leverage additional investment in the future resiliency of vital infrastructure.

Senator James Inhofe (R - OK) appeared on the March 15, 2012 MSNBC Rachel Maddow program to discuss his book «The Greatest Hoax: How the Global Warming Conspiracy Threatens Your Future.»

Requires the President to enter into an agreement with the National Governors Association Center for Best Practices to: (1) evaluate the utility to state, local, and regional decision makers of each Plan and of the anticipated and actual information outputs of the Program for development of state, local, and regional policies to reduce vulnerability to global change; and (2) recommend priorities for future global and regional climate change research and assessment.

Their Secure American Future Program, dedicated to raising public awareness of the threat posed by climate change and creating a movement for action, recently released Climate Security Index (5.3 MB download), a report that looks at the impacts of global climate disruption as a U.S. national security problem.

White House and Climate Change Science Program officials have never offered an honest public explanation of why the terms of that dismissal would have legally required (as distinct from an unofficial, secret political agreement) that the White House and the federal agencies suppress a taxpayer - funded, scientifically based assessment sponsored by the federal global change research program, even for purposes of using it as a scientific document or in program planning for research and future assesProgram officials have never offered an honest public explanation of why the terms of that dismissal would have legally required (as distinct from an unofficial, secret political agreement) that the White House and the federal agencies suppress a taxpayer - funded, scientifically based assessment sponsored by the federal global change research program, even for purposes of using it as a scientific document or in program planning for research and future assesprogram, even for purposes of using it as a scientific document or in program planning for research and future assesprogram planning for research and future assessments.

In order to address these serious and timely issues, Global Green's Security and Sustainability Program is organizing a series of roundtable discussions, «Energy Futures: Nuclear Power, Global Warming, and Nonproliferation,» to address the full life - cycle of nuclear energy.

In a sharp change from its cautious approach in the past, the National Academy of Sciences on Wednesday called for taxes on carbon emissions, a cap - and - trade program for such emissions or some other strong action to curb runaway global warming.Such actions, which would increase the cost of using coal and petroleum — at least in the immediate future — are necessary because «climate change is occurring, the Earth is warming... concentrations of carbon dioxide are increasing, and there are very clear fingerprints that link [those effects] to humans,» said Pamela A. Matson of Stanford University, who chaired one of five panels organized by the academy at the request of Congress to look at the science of climate change and how the nation should respond.

THE LIBRARY Legacy Infrastructure Repository Portal Enterprise 8 GLOBAL WARMING Impact of Human Activity or Natural Climate Variation / About Future of Scholarly Monograph Role of Subventions and Subsidies for Publication Market Impact on Research Topics / income through strategies like publishing program, software development, network services and duplication services.

Support the future of journalism by investing in projects like Global Voices: Truthdig Women Reporting and programs to mentor young journalists.

The CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS) will address the increasing challenge of global warming and declining food security on agricultural practices, policies and measures through a strategic collaboration between CGIAR and Future Earth.

Last year, on behalf of the U.S. Global Change Research Program, an expert team of scientists summarized the science of climate change and the impacts of climate change on the United States, now and in the future, and called the evidence of a warming climate «unequivocal,» primarily due to the use of fossil fuels — coal, oil, and gas — and the loss of forests.